Effect of Terazosin on the Lipid Profile in Patients with Symptomatic Benign Prostatic Hyperplasia

Publisher： Karger

E-ISSN： 1423-0399|67|2|156-159

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.67, Iss.2, 2001-08, pp. : 156-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Efficacy of Serenoa repens Treatment in Patients with Mild and Moderate Symptomatic Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 86, Iss. 3, 2011-02 ,pp. : 284-289

Karger

Access to resources Recommend Favorite

Management of Symptomatic Benign Prostatic Hyperplasia in Southern Italy: A Retrospective Analysis of the Sicilian-Calabrian Society of Urology (SSCU) of 32,000 Patients

By  

Urologia Internationalis, Vol. 71, Iss. 1, 2003-07 ,pp. : 16-21

Karger

Access to resources Recommend Favorite

Comparative Study of Therapeutic Effect of Dibenyline, Finasteride, and Combination Drugs for Symptomatic Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 60, Iss. 2, 1998-03 ,pp. : 85-91

Karger

Access to resources Recommend Favorite

Dutasteride: 21st Century medical therapy for symptomatic benign prostatic hyperplasia

By Shergill Iqbal S   Barua Jayanta M  

Therapy, Vol. 3, Iss. 3, 2006-05 ,pp. : 383-386

Future Medicine

Access to resources Recommend Favorite

A critical evaluation of technological innovations in the treatment of symptomatic benign prostatic hyperplasia

By  

BJU INTERNATIONAL, Vol. 81, Iss. S1, 1998-03 ,pp. : 56-63

John Wiley & Sons Inc

Access to resources Recommend Favorite